Background: Psoriatic arthritis (PsA) is a clinically heterogeneous disease. Clear consensual treatment guidance focused on the musculoskeletal manifestations of PsA would be advantageous.
Conclusions: We have updated the EULAR recommendations for the management of LN to facilitate homogenization of patient care.
The original European League Against Rheumatism recommendations for managing fibromyalgia assessed evidence up to 2005. The paucity of studies meant that most recommendations were ‘expert opinion’.
Results are announced at the European League Against Rheumatism (EULAR) Annual European Congress of Rheumatology of AMPLE (Abatacept Versus Adalimumab...
These updated, evidence-based recommendations are intended to help physicians caring for patients with BS.
New data presented at EULAR 2013, the Annual Congress of the European League Against Rheumatism, shows that apremilast from Celgene,...
Patient perspective to be included in future national recommendations for the use of biological drugs and biosimilars
These updated data-derived and consensus-derived recommendations will help rheumatologists to manage patients with SSc in an evidence-based way. These recommendations also give directions for future clinical research in SSc.
A follow-up study of Swedish patients with Rheumatoid Arthritis taking TNF inhibitors Humira, Enbrel and Remicade reveals that there is...